Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. Read the full story

Actavis has entered into an agreement with Mayne Pharma, under which it will divest the U.S. rights to the Doryx Read the full story

Harbin Gloria Pharma pay $380 million to acquire an 85% stake in Shanxi Powerdone, which makes chemical drugs and compound preparations. Read the full story

Pfizer has acquired a controlling interest in Redvax Read the full story

Otsuka Pharmaceutical announced an agreement with Avanir Pharmaceuticals, in which Otsuka America, acquires Avanir for USD 3.5 billion in an all-cash tender offer Read the full story

BioMarin Pharmaceutical and Prosensa Holding have entered into a definitive agreement in which BioMarin will offer to purchase all of the outstanding ordinary shares of Prosensa for $17.75 per share, for a total up front consideration of approximately $680 million Read the full story

Zoetis announced an agreement to purchase animal health assets of Abbott for a purchase price of $255 million Read the full story

In today's m&a news, Perrigo Company announced today that it will acquire Belgium-based Omega Pharma for $4.5 billion. Read the full story